| scholarly article | Q13442814 |
| P50 | author | Lisa Stamp | Q63042017 |
| P2093 | author name string | John L O'Donnell | |
| Peter T Chapman | |||
| Emon A R Khan | |||
| P2860 | cites work | Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis | Q34283776 |
| Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 | ||
| Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis | Q35547305 | ||
| Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis | Q35553035 | ||
| Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. | Q35553700 | ||
| Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis | Q35637252 | ||
| Cardiovascular disease in rheumatoid arthritis | Q36438681 | ||
| Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions | Q37415092 | ||
| Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives | Q37812524 | ||
| Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation | Q46433523 | ||
| Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. | Q53725487 | ||
| P433 | issue | 1 | |
| P921 | main subject | New Zealand | Q664 |
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 19-23 | |
| P577 | publication date | 2012-10-19 | |
| P1433 | published in | International Journal of Rheumatic Diseases | Q15764244 |
| P1476 | title | Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999-2008. | |
| P478 | volume | 16 |
Search more.